Bots
Last update: July 22, 2020
Pharmaceuticals
United States (USA)
Its 7 main executivesRecent executive movements at Bots
Simon Rubin has joined the company as Chairman of the Board (news posted on July 22 2020).
Yuri Abramov has joined the company as Director (news posted on July 22 2020).
Simon Rubin has joined the company as Director (news posted on July 22 2020).
Create an alert
to follow the executive moves at Bots.
Most searched biographies at Bots
- Paul Rosenberg, Co-Chief Executive Officer
- Simon Rubin, Chairman of the Board
- Yuri Abramov, Director
Click on an executive to view his biography >
Latest M&A news in Pharmaceuticals.
Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).
Other contacts in the Pharmaceuticals industry
Latest news about Bots
Press Releases – mCig Inc. a diversified and vertically integrated cannabis company.
Bots on Wikipedia, Google News & Yahoo Finance
Bots on LinkedIn, Twitter & YouTube
Bots has 2,035 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).
Contact by email its executives including Paul Rosenberg 
